Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.
Cancer Chemother Pharmacol
; 87(4): 465-474, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33398386
Full text:
1
Database:
MEDLINE
Main subject:
Sulfonamides
/
Triazoles
/
Bridged Bicyclo Compounds, Heterocyclic
Type of study:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2021
Type:
Article
Affiliation country:
United States